C135H151N35O7S5 — CID 158115384
2-[4-[4-(4-benzylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-cyclopropylethanone;2-[4-[4-(4-benzylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]-1-cyclopropylethanone;1-cyclopropyl-2-[4-[4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]ethanone;1-cyclopropyl-2-[4-[4-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(N-methylanilino)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]butan-2-one (PubChem CID 158115384) has the molecular formula C135H151N35O7S5 and a molecular weight of 2536.27 g/mol. Its IUPAC name is 2-[4-[4-(4-benzylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-cyclopropylethanone;2-[4-[4-(4-benzylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]-1-cyclopropylethanone;1-cyclopropyl-2-[4-[4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]ethanone;1-cyclopropyl-2-[4-[4-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(N-methylanilino)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]butan-2-one.
| Compound Name | 2-[4-[4-(4-benzylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-cyclopropylethanone;2-[4-[4-(4-benzylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]-1-cyclopropylethanone;1-cyclopropyl-2-[4-[4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]ethanone;1-cyclopropyl-2-[4-[4-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(N-methylanilino)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]butan-2-one |
|---|---|
| PubChem CID | 158115384 |
| Molecular Formula | C135H151N35O7S5 |
| Molecular Weight | 2536.27 g/mol |
| Exact Mass | 2534.11 |
| IUPAC Name | 2-[4-[4-(4-benzylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-cyclopropylethanone;2-[4-[4-(4-benzylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]-1-cyclopropylethanone;1-cyclopropyl-2-[4-[4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]ethanone;1-cyclopropyl-2-[4-[4-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(N-methylanilino)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]butan-2-one |
| SMILES | CCC(=O)Cc1ccc(Sc2nc(Nc3ccn[nH]3)cc(N(C)c3ccccc3)n2)cc1.C[C@@H]1CN(c2cc(Nc3ccn[nH]3)nc(Sc3ccc(CC(=O)C4CC4)cc3)n2)C[C@H](C)N1.Cc1cc(Nc2cc(N3CCN(Cc4ccccc4)CC3)nc(Sc3ccc(CC(=O)C4CC4)cc3)n2)n[nH]1.O=C(Cc1ccc(Sc2nc(Nc3ccn[nH]3)cc(N3CCN(CC(=O)N4CCOCC4)CC3)n2)cc1)C1CC1.O=C(Cc1ccc(Sc2nc(Nc3ccn[nH]3)cc(N3CCN(Cc4ccccc4)CC3)n2)cc1)C1CC1 |
| InChI | InChI=1S/C30H33N7OS.C29H31N7OS.C28H34N8O3S.C24H29N7OS.C24H24N6OS/c1-21-17-28(35-34-21)31-27-19-29(37-15-13-36(14-16-37)20-23-5-3-2-4-6-23)33-30(32-27)39-25-11-7-22(8-12-25)18-26(38)24-9-10-24;37-25(23-8-9-23)18-21-6-10-24(11-7-21)38-29-32-27(31-26-12-13-30-34-26)19-28(33-29)36-16-14-35(15-17-36)20-22-4-2-1-3-5-22;37-23(21-3-4-21)17-20-1-5-22(6-2-20)40-28-31-25(30-24-7-8-29-33-24)18-26(32-28)35-11-9-34(10-12-35)19-27(38)36-13-15-39-16-14-36;1-15-13-31(14-16(2)26-15)23-12-22(27-21-9-10-25-30-21)28-24(29-23)33-19-7-3-17(4-8-19)11-20(32)18-5-6-18;1-3-19(31)15-17-9-11-20(12-10-17)32-24-27-22(26-21-13-14-25-29-21)16-23(28-24)30(2)18-7-5-4-6-8-18/h2-8,11-12,17,19,24H,9-10,13-16,18,20H2,1H3,(H2,31,32,33,34,35);1-7,10-13,19,23H,8-9,14-18,20H2,(H2,30,31,32,33,34);1-2,5-8,18,21H,3-4,9-17,19H2,(H2,29,30,31,32,33);3-4,7-10,12,15-16,18,26H,5-6,11,13-14H2,1-2H3,(H2,25,27,28,29,30);4-14,16H,3,15H2,1-2H3,(H2,25,26,27,28,29)/t;;;15-,16+; |
| InChIKey | FQXZVGSBDVXCEI-XPBNADIDSA-N |
| XLogP | 21.97 |
| TPSA | 485.29 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 41 |
| Rotatable Bonds | 47 |
| Heavy Atoms | 182 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2536.27 |
| LogP ≤ 5 | 21.97 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 41 |